1. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates. Issue 7 (July 2015) Authors: Shintani, T.; Hayashido, Y.; Mukasa, H.; Akagi, E.; Hoshino, M.; Ishida, Y.; Hamana, T.; Okamoto, K.; Kanda, T.; Koizumi, K.; Yoshioka, Y.; Tani, R.; Toratani, S.; Okamoto, T. Journal: International journal of oral & maxillofacial surgery Issue: Volume 44:Issue 7(2015:Jul.) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Eldecalcitol (ED-71), an analog of 1α, 25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas. Issue 164 (November 2016) Authors: Shintani, T.; Rosli, S.N.Z.; Takatsu, F.; Choon, Y.F.; Hayashido, Y.; Toratani, S.; Usui, E.; Okamoto, T. Journal: Journal of steroid biochemistry and molecular biology Issue: Issue 164(2016) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Eldecalcitol (ED-71), an analog of 1α, 25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas. Issue 164 (November 2016) Authors: Shintani, T.; Rosli, S.N.Z.; Takatsu, F.; Choon, Y.F.; Hayashido, Y.; Toratani, S.; Usui, E.; Okamoto, T. Journal: Journal of steroid biochemistry and molecular biology Issue: Issue 164(2016) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗